Politics U.S. to see higher generic drug prices on tariffs: Indian pharma CEO Finance News Jul 24, 2026 A visitor walks next to the logo of the Indian multinational pharmaceutical company Dr. Reddy's Laboratories during… Read More...
Politics Eli Lilly will file for approval of retatrutide obesity drug in 2027 Finance News Jul 23, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake | ReutersEli… Read More...
Politics AstraZeneca stock dives 9% after heart drug trial misses target Finance News Jul 9, 2026 Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed to meet its… Read More...
Politics Medicare obesity drug GLP-1 coverage starting July 1 Finance News Jun 30, 2026 Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of… Read More...
Politics U.S. opens tariff probe targeting Germany’s drug pricing policies Finance News Jun 19, 2026 The U.S. has launched an investigation into Germany's pharma policies over what it referred to as "persistent… Read More...
Politics What’s next for the weight loss drug maker Finance News Jun 19, 2026 Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide… Read More...
Politics Why drug development is heading to orbit Finance News Jun 9, 2026 The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch… Read More...
Politics Weight loss drug maker stock sinks 25% as safety data spooks investors Finance News Jun 8, 2026 Shares of weight loss drug maker Zealand Pharma plummeted as much as 26% on Monday after new data on its experimental… Read More...
Politics AstraZeneca CEO says AI is reshaping drug development — and helping boost Finance News Jun 5, 2026 AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make… Read More...
Politics Abivax stock sinks over 30% after bowel disease drug trial update Finance News Jun 2, 2026 Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug for… Read More...